•  
  •  
 

Abstract

OBJECTIVE: To investigate the correlation between acute adverse reaction (AAR) and intravenous drip velocity of gatifloxacin. METHODS: Patients who had received intravenous gatifloxacin (0.2g/100ml) infusion in the Emergency Center, Zhongnan Hospital, Wuhan University, Wuhan, China from January to August 2012 were enrolled in this study. Patients were randomly divided into 3 groups according to different drip velocities: Group A: velocity

Article Type

Research Article

First Page

829

Last Page

831

Share

COinS